Cures that Kill: Biosecurity and the Dual-Use Dilemma

China represents a key player in biosecurity negotiations, as it has been both the victim of one of the worst biowarfare campaigns of the 20th century, at the hands of the Japanese, and has been a source of numerous emerging and re-emerging diseases, SARS and H5N1 being the best known. Of equal importance to China’s role as an international biosecurity actor is the burgeoning growth of its life science and biotechnology industries. This paper contains observations from an ongoing study into biosecurity in China. It is based on interviews and discussions in Beijing, Shanghai, and Guangzhou with life scientists and policy makers in infectious disease hospitals, district level Centers for Disease Control (CDC) offices, university research labs, the Chinese Academy of Sciences and the Ministry of Health.”
By Michael Barr

Author:
China Security
Publish Date:
2008